Jack Anders - 02 Sep 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Chief Financial Officer
Signature
/s/ Jack Anders
Issuer symbol
RVMD
Transactions as of
02 Sep 2025
Net transactions value
-$334,320
Form type
4
Filing time
04 Sep 2025, 19:05:35 UTC
Previous filing
18 Jun 2025
Next filing
18 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Anders Jack Chief Financial Officer C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY /s/ Jack Anders 04 Sep 2025 0001800668

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $7,542 +2,814 +2.5% $2.68 116,128 02 Sep 2025 Direct F1, F2
transaction RVMD Common Stock Options Exercise $9,214 +1,948 +1.7% $4.73 118,076 02 Sep 2025 Direct F1, F2
transaction RVMD Common Stock Sale $190,560 -4,762 -4% $40.02 113,314 02 Sep 2025 Direct F1, F2, F3
transaction RVMD Common Stock Options Exercise $15,084 +3,189 +2.8% $4.73 116,503 03 Sep 2025 Direct F1, F2
transaction RVMD Common Stock Options Exercise $34,833 +2,049 +1.8% $17.00 118,552 03 Sep 2025 Direct F1, F2
transaction RVMD Common Stock Sale $210,432 -5,238 -4.4% $40.17 113,314 03 Sep 2025 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -2,814 -100% $0.000000 0 02 Sep 2025 Common Stock 2,814 $2.68 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -1,948 -38% $0.000000 3,189 02 Sep 2025 Common Stock 1,948 $4.73 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -3,189 -100% $0.000000 0 03 Sep 2025 Common Stock 3,189 $4.73 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -2,049 -12% $0.000000 15,418 03 Sep 2025 Common Stock 2,049 $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
F2 Includes 54,213 RSUs.
F3 This transaction was executed in multiple trades in prices ranging from $40.00 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 This transaction was executed in multiple trades in prices ranging from $40.01 to $40.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.